PMID: 9177780May 15, 1997Paper

Construction of a 1.2-Mb contig surrounding, and molecular analysis of, the human CREB-binding protein (CBP/CREBBP) gene on chromosome 16p13.3

Genomics
R H GilesM H Breuning

Abstract

In the interest of cloning and analyzing the genes responsible for two very different diseases, the Rubinstein-Taybi syndrome (RTS) and acute myeloid leukemia (AML) associated with the somatic translocation t(8;16)(p11;p13.3), we constructed a high-resolution restriction map of contiguous cosmids (contig) covering 1.2 Mb of chromosome 16p13.3. By fluorescence in situ hybridization and Southern blot analysis, we assigned all tested RTS and t(8;16) translocation breakpoints to a 100-kb region. We have previously reported exact physical locations of these 16p breakpoints, which all disrupt one gene we mapped to this interval: the CREB-binding protein (CBP or CREBBP) gene. Intriguingly, mutations in the CBP gene are responsible for RTS as well as the t(8;16)-associated AML. CBP functions as an integrator in the assembly of various multiprotein regulatory complexes and is thus necessary for transcription in a broad range of transduction pathways. We report here the cloning, physical mapping, characterization, and full cDNA nucleotide sequence of the human CBP gene.

References

Aug 1, 1992·Human Molecular Genetics·P N BairdJ K Cowell
May 25, 1992·Nucleic Acids Research·S R HaynesI B Dawid
Aug 1, 1992·Genomics·R L StallingsM Breuning
Sep 1, 1992·American Journal of Medical Genetics·D LacombeJ Battin
Sep 15, 1992·Proceedings of the National Academy of Sciences of the United States of America·H ShizuyaM Simon
Jun 1, 1992·British Journal of Haematology·M Jotterand BellomoP M Schmidt
Aug 1, 1991·Proceedings of the National Academy of Sciences of the United States of America·C Aslanidis, P J de Jong
Sep 1, 1991·Proceedings of the National Academy of Sciences of the United States of America·N E Morton
May 15, 1991·Proceedings of the National Academy of Sciences of the United States of America·Z LarinH Lehrach
Mar 15, 1991·American Journal of Medical Genetics·K Imaizumi, Y Kuroki
Jun 1, 1990·Proceedings of the National Academy of Sciences of the United States of America·H M AlbertsenD Cohen
Jan 1, 1990·Cytogenetics and Cell Genetics·T KievitsP L Pearson
Feb 1, 1990·Proceedings of the National Academy of Sciences of the United States of America·E D Green, M V Olson
Jul 25, 1989·Nucleic Acids Research·L A BlondenG J van Ommen
Mar 13, 1995·American Journal of Medical Genetics·R W Miller, J H Rubinstein
Jun 1, 1993·Genetic Analysis, Techniques and Applications·J L LongmireG A Evans
Dec 31, 1993·Cell·UNKNOWN European Chromosome 16 Tuberous Sclerosis Consortium
Oct 28, 1993·Nature·J C ChriviaR H Goodman
Feb 1, 1993·Proceedings of the National Academy of Sciences of the United States of America·M K McCormickR Moyzis
Mar 1, 1996·Genes & Development·P DaiS Ishii
Apr 12, 1996·The Journal of Biological Chemistry·W YuanA Giordano
Jan 1, 1996·Cytogenetics and Cell Genetics·N A DoggettD F Callen
Jul 1, 1996·Molecular and Cellular Biology·R EcknerJ A Morgan

❮ Previous
Next ❯

Citations

Sep 20, 2008·Human Molecular Genetics·Melanie A KnightAndrew B Singleton
Aug 5, 1997·Proceedings of the National Academy of Sciences of the United States of America·O M SobuloN J Zeleznik-Le
Jan 17, 2015·Chemical Reviews·Beverley M Dancy, Philip A Cole
Jan 29, 2013·Gene·Mariam TajirAbdelaziz Sefiani
Apr 19, 2003·Clinical Genetics·Guiomar Pérez de NanclaresLuis Castaño
Feb 27, 2008·Proteins·Predrag RadivojacSean D Mooney
Nov 28, 2006·Journal of Cellular and Molecular Medicine·Guy FroyenPeter Marynen
Dec 20, 2013·American Journal of Medical Genetics. Part a·Susan A WoodsMohamed Khalifa
Feb 12, 2005·American Journal of Human Genetics·Jeroen H RoelfsemaDorien J M Peters
Oct 3, 1998·American Journal of Human Genetics·R H GilesM H Breuning
Aug 26, 2000·Genes, Chromosomes & Cancer·H Pirc-DanoewinataO A Haas
May 8, 2000·American Journal of Medical Genetics·F PetrijD J Peters
May 25, 2004·Oncogene·Narayanan Gopalakrishna IyerCarlos Caldas
May 3, 2007·European Journal of Human Genetics : EJHG·Marianne StefBenoît Arveiler
Aug 7, 2010·Journal of Biosciences·Neeti SharmaSharmila A Bapat
Oct 19, 2007·Expert Reviews in Molecular Medicine·Jeroen H Roelfsema, Dorien J M Peters
Dec 13, 2019·Experimental & Molecular Medicine·Kee-Beom KimKwon-Sik Park
Jan 2, 2014·Neuromolecular Medicine·Elizabeth ParkHoon Ryu
Apr 12, 2002·Oncogene·L Wuchao Yuan, Antonio Giordano
Nov 4, 2004·The Journal of Biological Chemistry·Hasan N RajabiBayar Thimmapaya
Jan 22, 2004·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Chi-Kwong SoChung S Yang

❮ Previous
Next ❯

Related Concepts

Related Feeds

Artificial Chromosomes

Artificial chromosomes are genetically engineered chromosomes derived from the DNA of a species. Discover the latest research on artificial chromosomes here.

AML: Role of LSD1 by CRISPR (Keystone)

Find the latest rersearrch on the ability of CRISPR-Cas9 mutagenesis to profile the interactions between lysine-specific histone demethylase 1 (LSD1) and chemical inhibitors in the context of acute myeloid leukemia (AML) here.

Acute Myeloid Leukemia

Acute myeloid leukemia (AML) is a clinically and genetically heterogeneous disease with approximately 20,000 cases per year in the United States. AML also accounts for 15-20% of all childhood acute leukemias, while it is responsible for more than half of the leukemic deaths in these patients. Here is the latest research on this disease.

Blood And Marrow Transplantation

The use of hematopoietic stem cell transplantation or blood and marrow transplantation (bmt) is on the increase worldwide. BMT is used to replace damaged or destroyed bone marrow with healthy bone marrow stem cells. Here is the latest research on bone and marrow transplantation.